Clinical Trials Directory

Trials / Completed

CompletedNCT00199628

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
University Hospital, Limoges · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Problems of compatibility between a mother and her child are frequent. The most well-known case can be illustrated by the fetomaternal blood group incompatibility (rhesus factor) which can induce severe anemia of the fetus. The investigators recently proved that incompatibility between mother and child can concern an organ leading to a tissular alloimmunization. For example, neonatal membranous glomerulonephritis (a kidney disease) can result from this mechanism. The purpose of this network is to detect and study neonatal diseases induced by tissular fetomaternal alloimmunization. The detection of these diseases will be performed by the mother's serum analysis.

Conditions

Timeline

Start date
2005-09-01
Primary completion
2013-08-01
Completion
2014-08-01
First posted
2005-09-20
Last updated
2019-01-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00199628. Inclusion in this directory is not an endorsement.